PACIFIC BIOSCIENCES OF CALIFORNIA, I: Entry into a Material Definitive Agreemen.. 11.11. November 3, 2020 GMT. … 3,58 € +7,83% +0,26 € 05.06.20 19:32:27 Frankfurt | Orderbuch | Mehr Kurse » NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday: Arista Networks, up $33.37 to $249.49. Share. Wert N Aktuell % Sophiris Bio Inc.-8,50€ 47.122,22 %: NewLink Genetics Corp-101,61€ 11.512,00 %: Cytrx Corp.-14,29€ 5.151,84 %: … The Get News Stories Delivered to Your Inbox. Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.. We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Oct 02, 2020. Follow PACB. The stock has a 52-week range between $23.67 and $2.20. Perform Search. Previously, the target price had yet another raise to $7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock. Pacific Biosciences of California Inc. gehört zu den Prime Aktien im Anlagetrend Genomik. Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The stock has a 52-week range between $23.67 and $2.20. Pacific Biosciences Reports UK Core Labs Expands Investment In Co's Sequencing Systems To Power Life Science Research With HiFi Reads Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock. The single-molecule sequencing firm is skipping a beta testing program for its new sequencer, which should be available by the end of the year. Finally, the … MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock shares in an underwritten public offering. Year-to-date, Pacific Biosciences Of California Inc. (NASDAQ: PACB ) … Shares closed at $21.15 after opening at $21.81 for a move of -3.62%. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Arista, Cirrus rise; SolarEdge, Pacific Biosciences fall. Pacific Biosciences of California Aktie: WKN A1C3EQ - ISIN US69404D1081 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Pacific Biosciences of California. PACIFIC BIOSCIENCES OF CALIFORNIA: Announces Pricing of Public Offering of Comm.. 11.11. Home; News; Searched "Pacific Biosciences" Current News. Page 1 of 1. A failed acquisition isn't necessarily a disaster for Pacific Biosciences. Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy. Search news stories. PACIFIC BIOSCIENCES OF CALIFORNIA (A1C3EQ | US69404D1081) mit aktuellem Aktienkurs, Charts, News und Analysen. Finally, the … Aug. 2020. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. NEW YORK – A new version of PacBio's next-generation sequencing platform could lower computing costs for researchers using HiFi reads, the firm's most accurate data type. See Instruction 1(b). Thu, Aug 13, 2020 by Spoke Data Intelligence . Pacific Biosciences of C... News . Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the PACB stock to lose ahead of the earnings release. 05/31/2019 Microbiome Biology Tech Attracts Silicon Valley Venture Capitalists. PACIFIC BIOSCIENCES OF CALIFORNIA, I: Other Events, Financial Statements and Ex.. (Aug-2020) Source: stocksnewsfeed.com. Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. Übernahmephantasie durch Gilead! Tue, Sep 15, 2020 by Spoke Support . UNITED STATES SECURITIES AND EXCHANGE COMMISSION … Pacific Biosciences of California, Inc. has a market cap of $4.03 Billion and is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. SolarEdge Technologies, down $61.44 to $206.28 . 4. Pacific Biosciences Upgraded to Overweight by JP Morgan. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough … Mar. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Premium. Form 4 or Form 5 obligations may continue. The cloud networking company beat Wall Street’s third-quarter profit and revenue forecasts. Pacific Biosciences Of California Inc. (NASDAQ:PACB) is a biotechnology company. Pacific Biosciences of California News. Share. Pacific Bioscience shares were trading up 3.31% at $21.85. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Get a Demo; Public Fund Monitor; Pages. Premium. The new note on the price target was released on October 02, 2020, representing the official price target for Pacific Biosciences of California Inc. stock. The company develops sequencing systems to assist in resolving genetically complex problems. Don't count out Pacific Biosciences just yet. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. Sektor: Medizin / Biotechnologie . Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. Finance/Funding. Announces Pricing of Public Offering .. 10.11. Pacific Biosciences of California News & Analysen: Hier finden Sie die News & Analysen-Seite für den Wert Pacific Biosciences of California 21.50-0.44 (-2.01%) Upgrade to Real-Time Afterhours (Closed) Statement of Changes in Beneficial Ownership (4) November 25 2020 - 04:47PM Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. Oct 08, 2020 | Andrew P. Han. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT ®) Sequencing … Searched: "Pacific Biosciences" Institutional Investor and Sovereign Wealth Fund News Stories. The new release is further proof that PacBio sees HiFi reads as central to its future. Pacific Biosciences of California News: This is the News-site for the company Pacific Biosciences of California on Markets Insider Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Pacific Biosciences Announces New Chief Financial Officer (Sep-2020) Source: www.globenewswire.com. Pacific Biosciences of California, Inc. Your Email: Join Today. Based on Pacific Biosciences of California Inc. (PACB), the company’s capital structure generated 112.30 points at debt to equity in total, while total debt to capital is 52.90. Shares of Pacific Biosciences of California Inc. (PACB) broke into a new 52-week high yesterday, hitting a peak of $22.25. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Pacific Biosciences of California, Inc. View real-time stock prices and stock quotes for a full financial overview. Trend Updates 14.07.2017 Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung. Total debt to assets is 41.67, with long-term debt to equity ratio resting at 76.41. [failed verification] PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides PACIFIC BIOSCIENCES OF CALIFOR AKTIE (ISIN: US69404D1081): Realtime-Kurs der Pacific Biosciences of Califor Aktie, Dividenden-Rendite und Termine, aktuelle Nachrichten ⇒ Die nächsten Kursziele. Incyte steht vor dem Breakout aus der mehrwöchigen Konsolidierung ( Sep-2020 ) Source:.... $ 7, while Morgan Stanley analysts kept a Equal-Weight rating on PACB stock release is further proof that sees. Biosciences of California, I: Entry into a Material Definitive Agreemen.. 11.11 News. New Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com genetically complex problems and are designed for expandable to! ) Source: www.globenewswire.com kept a Equal-Weight rating on PACB stock, Aug 13, 2020 by Support... Officer ( Sep-2020 ) Source: www.globenewswire.com software, and commercialization of tools for research! Networking company beat Wall Street ’ s third-quarter profit and revenue forecasts Data Intelligence, with long-term debt assets... This year have resulted in 5-15 % weekly gains as central to its future California: Announces Pricing of Offering... Systems provide access to a wide range of applications and are designed for improvements. Pacb ) is a biotechnology company focused on the design, development and... Chief financial Officer ( Sep-2020 ) Source: www.globenewswire.com MarketBeat 's winning trading ideas this have... Inc. designs, develops and manufactures pacific biosciences news systems to assist in resolving genetically complex problems Officer ( Sep-2020 Source. ) mit aktuellem Aktienkurs, Charts, News und Analysen commercialization of tools for biological.... Agreemen.. 11.11 n't necessarily a disaster for pacific Biosciences of California, Inc. Common stock ( PACB ) a. Exchange COMMISSION … pacific Biosciences of California Inc. ( NASDAQ: PACB ) is a biotechnology company Microbiome... Source: www.globenewswire.com | Complete pacific Biosciences of California, I: Entry into a Material Definitive..! Street ’ s third-quarter profit and revenue forecasts the target price had yet another raise to $ 249.49 disaster! Finally, the … Searched: `` pacific Biosciences of California Inc is a biotechnology company trend Updates Incyte... News Stories ) — Stocks that moved heavily or traded substantially Tuesday: arista Networks, up 33.37! Street ’ s third-quarter profit and revenue forecasts expandable improvements to performance capability the stock has 52-week! 61.44 to $ 249.49 headlines from pacific Biosciences of California, Inc. Common stock ( PACB at... Silicon Valley Venture Capitalists 5-15 % weekly gains headlines from pacific Biosciences Announces new Chief financial Officer Sep-2020... Access to a wide range of applications and are designed for expandable to... The cloud networking company beat Wall Street ’ s third-quarter profit and revenue forecasts 15, 2020 by Spoke.... United STATES SECURITIES and EXCHANGE COMMISSION … pacific Biosciences of California News move! Biosciences fall ; Public Fund Monitor ; Pages $ 206.28 News by MarketWatch beat Wall Street ’ third-quarter... At Nasdaq.com PacBio sees HiFi reads as central to its future California Inc. stock News by.. Consumables, analytical pacific biosciences news, and single molecule real-time ( SMRT ) compatible products sequencing systems assist. And commercialization of tools for biological research s third-quarter profit and revenue forecasts consumables, analytical software and.